Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-16
2009-12-22
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S602000, C548S469000, C564S084000
Reexamination Certificate
active
07635711
ABSTRACT:
Compounds of Formula (I)wherein R1, R2, R3, R4, R5, R6, and R7are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
REFERENCES:
patent: 4880839 (1989-11-01), Tucker
patent: 5039691 (1991-08-01), Spagnuolo et al.
patent: 6323199 (2001-11-01), Lehmann et al.
patent: 6329534 (2001-12-01), Kym et al.
patent: 6380223 (2002-04-01), Dow et al.
patent: 6436986 (2002-08-01), Kym et al.
patent: 6506766 (2003-01-01), Coghlan et al.
patent: 6583180 (2003-06-01), Link et al.
patent: 6858627 (2005-02-01), Bekkali et al.
patent: 2002/0077356 (2002-06-01), Jaroch et al.
patent: 2002/0156311 (2002-10-01), Link et al.
patent: 2003/0232823 (2003-12-01), Betageri et al.
patent: 2004/0010020 (2004-01-01), Kirrane, Jr. et al.
patent: 2004/0010148 (2004-01-01), Kirrane, Jr. et al.
patent: 2004/0029932 (2004-02-01), Bekkali et al.
patent: 2004/0097574 (2004-05-01), Marshall
patent: 2004/0116694 (2004-06-01), Jaroch et al.
patent: 2004/0162321 (2004-08-01), Kuzmich et al.
patent: 2004/0209875 (2004-10-01), Schmees et al.
patent: 2004/0224992 (2004-11-01), Cywin et al.
patent: 2004/0254249 (2004-12-01), Jaroch et al.
patent: 2005/0059714 (2005-03-01), Betageril et al.
patent: 2005/0131241 (2005-06-01), Song et al.
patent: 2005/0176706 (2005-08-01), Bekkali et al.
patent: 2005/0203128 (2005-09-01), Kirrane et al.
patent: 2005/0209488 (2005-09-01), Song et al.
patent: 2005/0234091 (2005-10-01), Regan et al.
patent: 2005/0234250 (2005-10-01), Lee et al.
patent: 2005/0282881 (2005-12-01), Bekkali et al.
patent: 2006/0014787 (2006-01-01), Kirrane et al.
patent: 2006/0154925 (2006-07-01), Kuzmich et al.
patent: 0 154 528 (1985-03-01), None
patent: 0311447 (1989-04-01), None
patent: 0 253 500 (1991-02-01), None
patent: 0 253 503 (1991-12-01), None
patent: 2 146 987 (1985-05-01), None
patent: WO 98/54159 (1985-05-01), None
patent: WO 96/19458 (1996-06-01), None
patent: WO 97/27852 (1997-08-01), None
patent: WO 99/41256 (1999-08-01), None
patent: WO 00/32584 (2000-06-01), None
patent: WO 00/66522 (2000-11-01), None
patent: WO 02/02565 (2002-01-01), None
patent: WO 02/10143 (2002-02-01), None
patent: WO 02064550 (2002-08-01), None
patent: WO 03/104195 (2003-12-01), None
patent: WO 2004/005278 (2004-01-01), None
patent: WO2004/019935 (2004-03-01), None
patent: WO2004/019935 (2004-03-01), None
patent: WO2004/071389 (2004-08-01), None
patent: WO 2006/046916 (2006-05-01), None
U.S. Appl. No. 10/639,080.
Vippagunta et al., Advanced Drug Delivery Reviews, p. 1.
Edwards, James P., et al; 5 Aryl-1,2-Dihydro-5H-chromeno[3m4-f]quinolines as Potent, Orally Active, Nonsteroidal Progesterone Receptor Agonists: The Effect of D-Ring Substituents, J. Med. Chem. 1998, 41, 303-310.
Pooley, Charlotte L.F. et al ; Discovery and Preliminary SAR Studies of a Novel, Nonsteroidal Progesterone Receptor Antagonist Pharmacophore, J. Med. Chem. 1998, 41, 3461-3466.
Hamann, Lawrence G., et al Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist; 4-Ethyl-1,2,3,4-tetrahydro-6-(trifluoromethyl)-8-pyridono[5,6-gl-quinoline (LG121071) J. Med. Chem. 1999, 42, 210-212.
Zhi, Lin, et al; 5 Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines: A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists, J. Med. Chem 1998, 41, 291-302.
Zhi, Lin, et al; 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a Novel Class of Nonsteroidal Progesterone Receptor Agonists; Effect of A-Ring Modification, J. Med. Chem 1999, 42, 1466-1472.
Tegley, Christopher, M., et al; 5 Benzylidene 1,2-Dihydrochromeno[3m4-f]quinolines, A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists—J. Med Chem., 1998, 41, 4354-4359.
Edwards, James, P. et al; Preparation, Resolution and Biological Evaluation of 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as Potent, Orally Active, Nonsteroidal Progestgerone Receptor Agonists: J. Med. Chem. 1998.41. 2779-2785.
Hamann, Lawrence, et al; Synthesis and Biological Activity of a Novel Series of Nonsteroidal Peripherally Selective Androgen Receptor Antagonists Derived from 1,2-Dihydropyridono[5,6-g]quinolines J. Med Chem 1998 41. 623. 639.
English Translation of WO 02/10143.
A. Sydney Bailey, et al; Further Examination of the Reactions of Simple Indoles with Arenesulphonyl Azides, PD 1973, pp. 1602-1606—XP 009014880.
Tatsuya Shono, et al; Electroorganic Chemistry. 81. Anodic Oxidation of Sulfonamides and Amidophosphates, J.Org. Chem. 1984, 49 3711-3716, XP002241082.
Valetine G. Nenajdenko, et al; A new convenient approach to chiral-aryl(heteroaryl)alkylamines, Tetrahedron: Asymmetry 12 (2001) 2517-2527.
B.T. Ho, et al; Central Nervous System Depressive Activity of Some Amides of Tryptamine J. Med. Chem., vol. 14, No. 6, 1971, pp. 553-554; XP 002261118.
J.P. Kutney, et al; Total synthesis of dregamine and Epidregamine, A General Route to 2 Acylindole Alkaloids, J. Am. Chem. Soc. vol. 100, No. 3, 1978, pp. 938-943—XP 002261119.
D.R.Lagidze, et al; Synthesis of Some new analogs of melatonin and beta-carboline from 4 phenylpentanoic acid; p. 637: XP 002261120.
Database Crossfire Bellstein, Online, Bellstein Institut zur Foerderung ger Chemischen Wissenschaften, Frankfurt am Main, DE, Database Accession No. BRN 7178110, 7178430, XP002261121.
Database Crossfire Bellstein, Online, Bellstein Institut zur Foerderung ger Chemischen Wissenschaften, Frankfurt am Main, DE, Database Accession No. BRN 318403, 341608, XP 002261122 & Hoshino & Kobavbash: Justus Liebigs Ann. Chem., vol. 520. 1935, pp. 11-17.
Patent Abstracts fo Japan, vol. 010, No. 004 (C-322), Jan. 9, 1986 & JP 60 163814 A (Wataru Mori), Aug. 26, 1985 abstract.
G. Palmisano, et al., Synthetic Studies on Indole Alkaloids. A Stereocontrolled Entry to the Cuanzine Structural Unit, Tetrahedron, Elsevier Science Publisher, Amsterdam, NL, vol. 45, No. 11, 1989 pp. 3583-3596, XP 002029549, ISSN 0040-4020.
Marshall, Dan, et al; a-Methyltryptomine Sulfonamide Derivatives as Novel Glucocorticoid Receptor Ligands; presented at the 227th American Chemical Society NAtional Meeting, Anaheim, CA Apr. 29-May 1, 2004.
Sergej N. Osipov,et al; a-Fluoromethyl Tryptophans via Imino Ene Reaction, Synlett 2001, No. 8, 1287-1289, Letter-XP-002387393.
David E. Sembower, et al; Enantiospecific Synthesis of a-(Fluoromethyl) Tryptophan Analogues: Interactions with Tryptophan Hydroxylase and Aromatic L-Amino Acid Decarboxylase; Journal of Medicinal Chemistry vol. 36, No. 3, pp. 305-313.
Kazuo Otsuki and Taeko Irino; Reaction of N-Haloamide, XXII, and Reaction of N,N-Dibromobenzene-sulfonamide with Safrole; CHem. Pharm. Bull. vol. 23(3) 482-486 (1975).
Betageri Rajashekhar
DiSalvo Darren
Kowalski Jennifer A.
Kuzmich Daniel
Regan John Robinson
Boehringer-Ingelheim Pharmaceuticals, Inc.
Chu Yong
Devlin Mary-Ellen M.
Morris Michael P.
Witkowski Timothy X.
LandOfFree
Glucocorticoid mimetics, methods of making them,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucocorticoid mimetics, methods of making them,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid mimetics, methods of making them,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107419